HuR and other turnover- and translation-regulatory RNA-binding proteins: Implications for the kidney

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 6, 2014, Pages

  Rudolf, Pullmann ^a   Rabb, Hamid ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Nephrology; Renal; RNA turnover; RNA binding protein

Indexed keywords

ANTIGEN; HUMAN ANTIGEN R; MESSENGER RNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNP D0; HU ANTIGEN; MICRORNA; POLYADENYLIC ACID BINDING PROTEIN; TIA1 PROTEIN, HUMAN; TRISTETRAPROLIN; Y BOX BINDING PROTEIN 1; YBX1 PROTEIN, HUMAN; ZFP36 PROTEIN, HUMAN;

ACID BASE BALANCE; AGING; ANEMIA; ANGIOGENESIS; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL TONE; GENE CONTROL; GENE EXPRESSION; HUMAN; HYPERTENSION; IMMUNOREGULATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY METABOLISM; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; ANIMAL; IMMUNOLOGY; KIDNEY; METABOLISM; NEPHROLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; RENAL; RIBONUCLEIC ACID TURNOVER; RNA-BINDING PROTEIN;

NEPHROLOGY; RENAL; RNA TURNOVER; RNA-BINDING PROTEIN;

ACID-BASE EQUILIBRIUM; AGING; ANIMALS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; KIDNEY; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; POLY(A)-BINDING PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS; TRISTETRAPROLIN; VASCULAR CALCIFICATION; Y-BOX-BINDING PROTEIN 1;

EID: 84900307097     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00270.2013     Document Type: Review

References (90)

1. Abdelmohsen K, Kim MM, Srikantan S, Mercken EM, Brennan SE, Wilson GM, Cabo R, Gorospe M. miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 9: 1354-1359, 2010.
2. Adams DJ, Beveridge DJ, van der Weyden L, Mangs H, Leedman PJ, Morris BJ. HADHB, HuR, and CP1 bind to the distal 3'-untranslated region of human renin mRNA and differentially modulate renin expression. J Biol Chem 278: 44894-44903, 2003.
3. Akkina S, Becker BN. MicroRNAs in kidney function and disease. Transl Res 157: 236-240, 2011.
4. Akool el-S, Kleinert H, Hamada FM, Abdelwahab MH, Förstermann U, Pfeilschifter J, Eberhardt W. Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNAstabilizing factor HuR. Mol Cell Biol 23: 4901-4916, 2003.
5. Al-Ahmadi W, Al-Ghamdi M, Al-Haj L, Al-Saif M, Khabar KS. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-regulation. Nucleic Acids Res 37: 3612-3624, 2009.
6. Ayupova DA, Singh M, Leonard EC, Basile DP, Lee BS. Expression of the RNAstabilizing protein HuR in ischemia-reperfusion injury of rat kidney. Am J Physiol Renal Physiol 297: F95-F105, 2009.
7. Baltz AG, Munschauer M, Schwanhäusser B, Vasile A, Murakawa Y, Schueler M, Youngs N, Penfold-Brown D, Drew K, Milek M, Wyler E, Bonneau R, Selbach M, Dieterich C, Landthaler M. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell 46: 674-690, 2012.
8. Buys ES, Raher MJ, Kirby A, Shahid M, Baron DM, Hayton SR, Tainsh LT, Sips PY, Rauwerdink KM, Yan Q, Tainsh RE, Shakartzi HR, Stevens C, Decaluwé K, Rodrigues-Machado Mda G, Malhotra R, Van de Voorde J, Wang T, Brouckaert P, Daly MJ, Bloch KD. Genetic modifiers of hypertension in soluble guanylate cyclase _1-deficient mice. J Clin Invest 122: 2316-2325, 2012.
9. Chen F, Shyu AB, Shneider BL. Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability. Hepatology 54: 1371-1378, 2011.
10. Cok SJ, Acton SJ, Morrison AR. The proximal region of the 3=- untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J Biol Chem 278: 36157-36162, 2003.
11. Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science. GeneCards.org (Online). www.genecards.org [10 May 2013].
12. Cuevas S, Zhang Y, Yang Y, Escano C, Asico L, Jones JE, Armando I, Jose PA. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension 59: 446-452, 2012.
13. Cybulsky AV, Takano T, Papillon J, Hao W, Mancini A, Di Battista JA, Cybulsky MI. The 3'-untranslated region of the Ste20-like kinase SLK regulates SLK expression. Am J Physiol Renal Physiol 292: F845-F852, 2007.
14. Dai W, Zhang G, Makeyev EV. RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage. Nucleic Acids Res 40: 787-800, 2012.
15. Das F, Dey N, Venkatesan B, Kasinath BS, Ghosh-Choudhury N, Choudhury GG. High glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy. Cell Signal 23: 1311-1319, 2011.
16. Day RT, Cavaglieri Rde C, Tabatabaimir H, Mantravadi V, Lee MJ, Barnes JL, Kasinath BS, Feliers D. Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2). Cell Signal 22: 1849-1857, 2010.
17. Deng A, Arndt MA, Satriano J, Singh P, Rieg T, Thomson S, Tang T, Blantz RC. Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade. Am J Physiol Renal Physiol 299: F1365-F1373, 2010.
18. Derrigo M, Cestelli C, Savettieri G, Di Liegro I. RNA-protein interactions in the control of stability and localization of messenger RNA. Int J Mol Med 5: 111-123, 2000.
19. Dhakras PS, Hajarnis S, Taylor L, Curthoys NP. cAMP-dependent stabilization of phosphoenolpyruvate carboxykinase mRNA in LLCPK1- F+ kidney cells. Am J Physiol Renal Physiol 290: F313-F318, 2006.
20. Doller A, Akool el-S, Huwiler A, Müller R, Radeke HH, Pfeilschifter J, Eberhardt W. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cδ elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol 28: 2608-2625, 2008.
21. Doller A, Gauer S, Sobkowiak E, Geiger H, Pfeilschifter J, Eberhardt W. Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. Am J Pathol 174: 1252-1263, 2009.
22. Doller A, Huwiler A, Muller R, Radeke HH, Pfeilschifter J, Eberhardt W. Protein kinase C alpha-dependent phosphorylation of the mRNAstabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol Biol Cell 18: 2137-2148, 2007.
23. Fan J, Yang X, Wang W, Wood WH, Becker KG, Gorospe M. Global analysis of stress-regulated mRNA turnover by using cDNA arrays. Proc Natl Acad Sci USA 99: 10611-10616, 2002.
24. Fechir M, Linker K, Pautz A, Hubrich T, Kleinert H. The RNA binding protein TIAR is involved in the regulation of human iNOS expression. Cell Mol Biol (Noisy-le-grand) 51: 299-305, 2005.
25. Feliers D, Lee MJ, Ghosh-Choudhury G, Bomsztyk K, Kasinath BS. Heterogeneous nuclear ribonucleoprotein K contributes to angiotensin II stimulation of vascular endothelial growth factor mRNA translation. Am J Physiol Renal Physiol 293: F607-F615, 2007.
26. Fraser DJ, Phillips AO, Zhang X, van Roeyen CR, Muehlenberg P, En-Nia A, Mertens PR. Y-box protein-1 controls transforming growth factor-beta1 translation in proximal tubular cells. Kidney Int 73: 724-732, 2008.
27. Fujihara CK, Antunes GR, Mattar AL, Andreoli N, Malheiros DM, Noronha IL, Zatz R. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney. Kidney Int 64: 2172-2181, 2003.
28. Galbán S, Kuwano Y, Pullmann R Jr, Martindale JL, Kim HH, Lal A, Abdelmohsen K, Yang X, Dang Y, Liu JO, Lewis SM, Holcik M, Gorospe M. RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1α. Mol Cell Biol 28: 93-107, 2008.
29. Goldberg MA, Gaut CC, Bunn HF. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 77: 271-277, 1991.
30. Goldberg-Cohen I, Furneauxb H, Levy AP. A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 277: 13635-13640, 2002.
31. Gratacós FM, Brewer G. The role of AUF1 in regulated mRNA decay. Wiley Interdiscip Rev RNA 1: 457-473, 2010.
32. Gueydan C, Droogmans L, Chalon P, Huez G, Caput D, Kruys V. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor α mRNA. J Biol Chem 274: 2322-2326, 1999.
33. Gummadi L, Taylor L, Courthoys NP. Concurrent binding and modifications of AUF1 and HuR mediate the pH responsive stabilization of phosphoenolpyruvate carboxykinase mRNA in kidney cells. Am J Physiol Renal Physiol 303: F1545-F1554, 2012.
34. Guo X, Wu Y, Hartley RS. MicroRNA-125a respresses cell growth by targeting HuR in breast cancer. RNA Biol 6: 575-583, 2009.
35. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M Jr, Jungkamp AC, Munschauer M, Ulrich A, Wardle GS, Dewell S, Zavolan M, Tuschl T. Transcriptome- wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141, 2010.
36. Hägele S, Kühn U, Böning M, Katschinski DM. Cytoplasmic polyadenylation- element-binding protein (CPEB)1 and 2 bind to the HIF-1α mRNA 3́-UTR and modulate HIF-1_ protein expression. Biochem J 417: 235-246, 2009.
37. Hajarnis S, Schroeder JM, Curthoys NP. 3́-Untranslated region of phosphoenolpyruvate carboxykinase mRNA contains multiple instability elements that bind AUF1. J Biol Chem 280: 28272-28280, 2005.
38. Hanson ES, Foot LM, Leibold EA. Hypoxia post-translationally activates iron-regulatory protein 2. J Biol Chem 274: 5047-5052, 1999.
39. Hanssen L, Frye BC, Ostendorf T, Alidousty C, Djudjaj S, Boor P, Rauen T, Floege J, Mertens PR, Raffetseder U. Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney. J Immunol 187: 298-308, 2011.
40. Huwiler A, Akool el-S, Aschrafi A, Hamada FM, Pfeilschifter J, Eberhardt W. ATP potentiates interleukin-1β-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR. J Biol Chem 278: 51758-51769, 2003.
41. Ibrahim H, Lee YJ, Curthoys NP. Renal response to metabolic acidosis: role of mRNA stabilization. Kidney Int 73: 11-18, 2008.
42. +-translocating ATPase mRNA during cellular energy depletion. J Biol Chem 280: 37957-37964, 2005.
43. Jeyaraj SC, Dakhlallah D, Hill SR, Lee BS. Expression and distribution of HuR during ATP depletion and recovery in proximal tubule cells. Am J Physiol Renal Physiol 291: F1255-F1263, 2006.
44. Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features. Arthritis Rheum 58: 1226-1236, 2008.
45. Kandasamy K, Joseph K, Subramaniam K, Raymond JR, Tholanikunnel BG. Translational control of β2-adrenergic receptor mRNA by T-cell-restricted intracellular antigen-related protein. J Biol Chem 280: 1931-1943, 2005.
46. Kasinath BS, Feliers D, Sataranatarajan K, Ghosh Choudhury G, Lee MJ, Mariappan MM. Regulation of mRNA translation in renal physiology and disease. Am J Physiol Renal Physiol 297: F1153-F1165, 2009.
47. Kato M, Wang L, Putta S, Wang M, Yuan H, Sun G, Lanting L, Todorov I, Rossi JJ, Natarajan R. Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-α-induced collagen expression in kidney cells. J Biol Chem 285: 34004-34015, 2010.
48. Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8: 533-543, 2007.
49. Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 23: 1743-1748, 2009.
50. Klöss S, Rodenbach D, Bordel R, Mülsch A. Human-antigen R (HuR) expression in hypertension: downregulation of the mRNA stabilizing protein HuR in genetic hypertension. Hypertension 45: 1200-1206, 2005.
51. Klöss S, Srivastava R, Mülsch A. Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR. Mol Pharmacol 65: 1440-1451, 2004.
52. Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol 22: 216-224, 2011.
53. Lebedeva S, Jens M, Theil K, Schwanhausser B, Selbach M, Landthaler M, Rajewsky N. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 43: 340-352, 2011.
54. Leipuviene R, Theil EC. The family of iron responsive RNA structures regulated by changes in cellular iron and oxygen. Cell Mol Life Sci 64: 2945-2955, 2007.
55. Levy NS, Chung S, Furneaux H, Levy AP. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417-6423, 1998.
56. Lu JY, Sadri N, Schneider RJ. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev 20: 3174-3184, 2006.
57. Maisonneuve C, Guilleret I, Vick P, Weber T, Andre P, Beyer T, Blum M, Constam DB. Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow. Development 136: 3019-3030, 2009.
58. Martín-Garrido A, González-Ramos M, Griera M, Guijarro B, Cannata- Andia J, Rodriguez-Puyol D, Rodriguez-Puyol M, Saura M. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR. Arterioscler Thromb Vasc Biol 31: 567-573, 2011.
59. Masuda K, Marasa B, Martindale JL, Halushka MK, Gorospe M. Tissueand age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation. Aging (Albany NY) 1: 681-698, 2009.
60. McGary EC, Rondon IJ, Beckman BS. Post-transcriptional regulation of erythropoietin mRNA stability by erythropoietin mRNA-binding protein. J Biol Chem 272: 8628-8634, 1997.
61. Moore MJ. From birth to death: the complex lives of eukaryotic mRNAs. Science 309: 1514-1518, 2005.
62. Morris BJ, Adams DJ, Beveridge DJ, van der Weyden L, Mangs H, Leedman PJ. cAMP controls human renin mRNA stability via specific RNA-binding proteins. Acta Physiol Scand 181: 369-373, 2004.
63. Mufti J, Hajarnis S, Shepardson K, Gummadi L, Taylor L, Curthoys NP. Role of AUF1 and HuR in the pH-responsive stabilization of phosphoenolpyruvate carboxykinase mRNA in LLC-PK-F cells. Am J Physiol Renal Physiol 301: F1066-F1077, 2011.
64. Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M, Ascano M Jr, Tuschl T, Ohler U, Keene JD. Interactive regulatory mapping indicates that the RNA binding protein HuR couples pre-mRNA processing and mRNA stability. Mol Cell 43: 327-339, 2011.
65. Nechama M, Uchida T, Mor Yosef-Levi I, Silver J, Naveh-Many T. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest 119: 3102-3114, 2009.
66. Orphanides G, Reinberg D. A unified theory of gene expression. Cell 108: 439-451, 2002.
67. Paukku K, Backlund M, De Boer RA, Kalkkinen N, Kontula KK, Lehtonen JY. Regulation of AT1R expression through HuR by insulin. Nucleic Acids Res 40: 5250-5261, 2012.
68. Perlewitz A, Nafz B, Skalweit A, Fähling M, Persson PB, Thiele BJ. Aldosterone and vasopressin affect α- and γ-ENaC mRNA translation. Nucleic Acids Res 38: 5746-5760, 2012.
69. Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, Chen S, Gueydan C, Kruys V, Streuli M, Anderson P. TIA-1 is a translational silencer that selectively regulates the expression of TNF-α. EMBO J 19: 4154-4163, 2000.
70. Pont AR, Sadri N, Hsiao SJ, Smith S, Schneider RJ. MRNA decay factor AUF-1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. Mol Cell 47: 5-15, 2012.
71. Pullmann R Jr, Juhaszova M, López de Silanes I, Kawai T, Mazan- Mamczarz K, Halushka MK, Gorospe M. Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR. J Biol Chem 280: 22819-22826, 2005.
72. Pullmann R Jr, Kim HH, Abdelmohsen K, Lal A, Martindale JL, Yang X, Gorospe M. Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol Cell Biol 27: 6265-6278, 2007.
73. Pullmann R Jr, Ko GJ, Marasa BS, Juhaszova M, Huang Y, Womer KL, Rabb H. HuR: a Candidate Post-Transcriptional Regulator of Immune Responses During AKI. Denver, CO: 43rd Annual Meeting of American Society of Nephrology, 2010.
74. Rondon IJ, Scandurro AB, Wilson RB, Beckman BS. Changes in redox affect the activity of erythropoietin RNA binding protein. FEBS Lett 359: 267-270, 1995.
75. Sataranatarajan K, Lee MJ, Mariappan MM, Feliers D. PKCδ regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K. Cell Signal 20: 969-977, 2008.
76. Schepens B, Tinton SA, Bruynooghe Y, Beyaert R, Cornelis S. The polypyrimidine tract-binding protein stimulates HIF-1_ IRES-mediated translation during hypoxia. Nucleic Acids Res 33: 6884-6894, 2005.
77. Schroeder JM, Ibrahim H, Taylor L, Curthoys NP. Role of deadenylation and AUF1 binding in the pH-responsive stabilization of glutaminase mRNA. Am J Physiol Renal Physiol 290: F733-F740, 2006.
78. Schroeder JM, Liu W, Curthoys NP. pH-responsive stabilization of glutamate dehydrogenase mRNA in LLC-PK1-F+ cells. Am J Physiol Renal Physiol 285: F258-F265, 2003.
79. Sheflin LG, Zou AP, Spaulding SW. Androgens regulate the binding of endogenous HuR to the AU-rich 3'UTRs of HIF-1α and EGF mRNA. Biochem Biophys Res Commun 322: 644-651, 2004.
80. Singh M, Martinez AR, Govindaraju S, Lee BS. HuR inhibits apoptosis by amplifying Akt signaling through a positive feedback loop. J Cell Physiol 228: 182-189, 2013.
81. Skalweit A, Doller A, Huth A, Kähne T, Persson PB, Thiele BJ. Posttranscriptional control of renin synthesis: identification of proteins interacting with renin mRNA 3'-untranslated region. Circ Res 92: 419-427, 2003.
82. Srikantan S, Gorospe M. HuR function in disease. Front Biosci 17: 189-205, 2012.
83. Srikantan S, Tominaga K, Gorospe M. Functional interplay between RNA-binding protein HuR and microRNAs. Curr Protein Pept Sci 13: 372-379, 2012.
84. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ. A pathogenetic role for TNF α in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454, 1996.
85. Tran U, Zakin L, Schweickert A, Agrawal R, Döger R, Blum M, De Robertis EM, Wessely O. The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. Development 137: 1107-1116, 2010.
86. van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11: 644-656, 2011.
87. Xu F, Zhang X, Lei Y, Liu X, Liu Z, Tong T, Wang W. Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. J Cell Biochem 111: 727-734, 2010.
88. Yu Q, Cok SJ, Zeng C, Morrison AR. Translational repression of human matrix metalloproteinases-13 by an alternatively spliced form of T-cellrestricted intracellular antigen-related protein (TIAR). J Biol Chem 278: 1579-1584, 2003.
89. Zhao G, Xu MJ, Zhao MM, Dai XY, Kong W, Wilson GM, Guan Y, Wang CY, Wang X. Activation of nuclear factor-κB accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int 82: 34-44, 2012.
90. Zimmer M, Ebert BL, Neil C, Brenner K, Papaioannou I, Melas A. Small-molecule inhibitors of HIF-2a translation link its 5'UTR ironresponsive element to oxygen sensing. Mol Cell 32: 838-848, 2008.